Upcoming event

Overall survival (OS) by circulating tumor DNA (ctDNA) status in patients with post-operative muscle-invasive urothelial carcinoma (MIUC) treated with atezolizumab (atezo): update from IMvigor010

2022-07-04

“Overall survival (OS) by circulating tumor DNA (ctDNA) status in patients with post-operative muscle-invasive urothelial carcinoma (MIUC) treated with atezolizumab (atezo): update from IMvigor010” presented by Prof. J├╝rgen Gschwend at EAU22.

Also watch the interview with Prof. Gschwend on this presentation. 

Tags: EAU22